Robert E. Rydell
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in ⓘ
-
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 4
- Genetics 6
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- John M. Bennett (1 shared paper)Costan W. Berard (1 shared paper)Hugh Bonner (1 shared paper)Richard S. Neiman (1 shared paper)Maurice Barcos (1 shared paper)Risa B. Mann (1 shared paper)Martin M. Oken (8 shared papers)F. W. Hoffbauer (1 shared paper)
- Journals
- JNCI Journal of the National Cancer Institute (3 papers)The American Journal of Medicine (3 papers)British Journal of Haematology (2 papers)Cancer (2 papers)American Journal of Hematology (2 papers)
- Partner nations
- United StatesSweden
In The Last Decade
Robert E. Rydell
27 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Hematology 1.1k
- Genetics 484
- Emergency Medicine 256
- Pathology and Forensic Medicine 237
- Hepatology 89
Countries citing papers authored by Robert E. Rydell
This map shows the geographic impact of Robert E. Rydell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Rydell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Rydell more than expected).
Fields of papers citing papers by Robert E. Rydell
This network shows the impact of papers produced by Robert E. Rydell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Rydell. The network helps show where Robert E. Rydell may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Rydell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases Hit paper breakdown → | 1981 | 745 |
| 2 | 1988 | 187 | |
| 3 | 1956 | 172 | |
| 4 | 1983 | 118 | |
| 5 | 1980 | 113 | |
| 6 | 1991 | 71 | |
| 7 | 1973 | 62 | |
| 8 | On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat. | 1972 | 49 |
| 9 | 1991 | 30 | |
| 10 | Inversion of chromosome 16 and dysplastic eosinophils in accelerated phase of chronic myeloid leukemia. | 1992 | 27 |
| 11 | 1986 | 26 | |
| 12 | Structure-activity relationships of N-acylarylhydroxylamines in the rat. | 1970 | 25 |
| 13 | 1971 | 21 | |
| 14 | 1980 | 17 | |
| 15 | Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates. | 1977 | 17 |
| 16 | 1978 | 16 | |
| 17 | Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids. | 1973 | 15 |
| 18 | 1981 | 15 | |
| 19 | Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo. | 1971 | 9 |
| 20 | The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles. | 1975 | 9 |
About Robert E. Rydell
Robert E. Rydell is a scholar working on Hematology, Genetics, Biotechnology, Pharmaceutical Science and Emergency Medicine, having authored 27 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Cancer Research and Treatments (3 papers), Glutathione Transferases and Polymorphisms (3 papers), Hematological disorders and diagnostics (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Alcohol Consumption and Health Effects (2 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (484 citations), Emergency Medicine (256 citations), Pathology and Forensic Medicine (237 citations) and Hepatology (89 citations). Robert E. Rydell has collaborated with scholars based in United States and Sweden. Frequent co-authors include John M. Bennett, Costan W. Berard, Hugh Bonner, Richard S. Neiman, Maurice Barcos, Risa B. Mann, Martin M. Oken, F. W. Hoffbauer, Kathy Foucar and Heike Gutmann. Their work appears in journals such as JNCI Journal of the National Cancer Institute, The American Journal of Medicine, British Journal of Haematology, Cancer and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.